Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-06 · accession 0001104659-23-002317 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-09 | 2023-01-06 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $39.90 | -174 | 1,644 | -10% | -$6,943 |
| D | 2023-01-09 | 2023-01-06 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $9.13 | +174 | 1,818 | +11% | +$1,589 |
| D | 2023-01-09 | 2023-01-06 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | -174 | 9,826 | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-06 | S | D | 174 | $39.90 | 1,644 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-06 | M | A | 174 | $9.13 | 1,818 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-01-06 | M | D | 174 | $0.00 | 9,826 | D | $9.13 · — to 2025-03-03 | 174 Common Stock | (F2) The option vested in four equal annual installments beginning on March 3, 2016. |